Case report
===========

A 37-year-old female with retroviral disease was brought to casualty by caregivers because she was confused. The confusion was preceded by severe headache for 3 weeks. She had no history of vomiting or neck stiffness. She had started antiretroviral drugs 2 months earlier and subsequently defaulted.

On initial clinical examination, the patient was confused (not orientated to time, place, or person), pyrexial, and pale. She was normotensive (108/80 mmHg) but had a tachycardia of 107 beats per minute. The cardiac examination was otherwise normal. She was tachypneic with a respiratory rate of 22 breaths per minute and crackles throughout both lung fields. Neurologic examination identified neck stiffness without localizing signs.

Blood tests, microbiology, lumbar puncture analysis, and a chest film were done ([Tables 1](#t1-ijgm-6-781){ref-type="table"}--[6](#t6-ijgm-6-781){ref-type="table"} and [Figure 1](#f1-ijgm-6-781){ref-type="fig"}). The patient had normocytic normochromic anemia, hyponatremia, and a slightly raised alanine transaminase. Her viral load was raised (678,233 copies/mL) and her CD4 count was low (155.28 × 10^6^/L). Cerebrospinal fluid analysis showed an increase in lymphocytes, a raised protein level, and decreased glucose ([Table 4](#t4-ijgm-6-781){ref-type="table"}). India ink staining and a *Cryptococcus* latex antigen test were both negative ([Table 4](#t4-ijgm-6-781){ref-type="table"}). Sputum analysis and blood cultures were negative for Mycobacteria ([Table 7](#t7-ijgm-6-781){ref-type="table"}).

The anterior-posterior supine chest film with the patient rotated to the right ([Figure 1](#f1-ijgm-6-781){ref-type="fig"}) showed bilateral nodular infiltrates with hilar and mediastinal lymphadenopathy not excluded. A veiling pleural effusion was noted on the left, and the left cardiac border was obscured by confluent opacification in the lingular segment of the left upper lobe.

The patient was initially assessed as having disseminated tuberculosis with central nervous system involvement, specifically meningitis. She was admitted to the medical ward and started on antituberculosis therapy, glucocorticosteroids, and supportive care.

On day 2, the patient developed both inspiratory and expiratory stridor and her initial respiratory distress worsened, with the respiratory rate increasing to 46 breaths per minute. The patient was started on adrenalin nebulization. The patient was intubated in theater and then transferred to the high care ward with a T-piece attached to the endotracheal tube. The glottis appeared normal during endotracheal intubation. At this point she was normotensive (113/73 mmHg), tachycardiac (152 beats per minute), and tachypneic (54 breaths per minute). Her oxygen saturation was 94% on 40% oxygen via a T-piece. A computed tomography (CT) scan of her brain and chest were requested. Unfortunately, the CT scanner at the base hospital was not working and the patient was deemed too unstable for transport to a CT scanner 2 hours away. High-dose cotrimoxazole, piperacillin/tazobactam, and amikacin were initiated. The patient remained pyrexial with a temperature of 38°C.

On day 4, the patient's oxygen saturation dropped to 92% and her arterial oxygen was 59 mmHg on 40% oxygen. Her chest film suggested a left-sided pleural effusion. Her blood pressure was also decreasing and central venous pressure was low (0 cm H~2~O). The central venous pressure was optimized and inotropic cardiac support was initiated. The patient's level of consciousness improved.

On day 7, she developed worsening hepatic impairment so her treatment was changed to a "liver-friendly" tuberculosis regimen. Clinical improvement was noted (improved level of consciousness, pulse 104 per minute, blood pressure 94/68 mmHg, oxygen saturation 100% on 60% T-piece oxygen, central venous pressure 8 cm H~2~O, respiratory rate 36 breaths per minute) and it was decided to taper her inotropic support.

On day 12, the patient extubated herself. Her vitals at this point were as follows: pulse 102 per minute, oxygen saturation 98% on 40% face mask oxygen, respiratory rate 30 breaths minute, and blood pressure 147/71 mmHg. Vesicular lesions with a dermatomal distribution were noted on her buttock and the patient developed diarrhea. The endotracheal tube and stool were sent for microbiologic analysis ([Table 7](#t7-ijgm-6-781){ref-type="table"}). Approximately 9 hours later, the patient desaturated and was reintubated. The patient then underwent a tracheostomy.

The following day she suffered a cerebrovascular accident with left hemiplegia. The patient died later that day, approximately 2 weeks after admission.

Discussion
==========

The combination of tuberculosis meningitis and stridor has not been reported previously. In our index patient, there are two possible causes for her stridor. One possibility is a mediastinal mass and the other is a central mechanism. This discussion will focus on the central mechanism of stridor. During laryngoscopy and intubation, the patient's glottis was macroscopically normal and she was intubated without difficulty. The chest film did not show obvious mediastinal enlargement. However, one cannot rule out a mediastinal mass as a possible cause of stridor. The chest film was an anterior-posterior supine view (limiting interpretation) and not sensitive enough to rule out a mediastinal mass. Ideally, a CT scan or magnetic resonance imaging should have been done. These aforementioned imaging modalities would have assisted in ruling out a mediastinal mass as a cause of stridor.

The cerebrospinal analysis (elevated lymphocytes and protein) suggested tuberculosis meningitis. We hypothesized that tuberculosis meningitis may have resulted in stridor via a central mechanism. In South Africa, tuberculosis meningitis is a common central nervous system form of tuberculosis. The cerebrospinal fluid analysis typically shows increased protein and lymphocytes. Currently, diagnostic tests (including polymerase chain reaction) are not sensitive enough to detect tuberculosis meningitis[@b1-ijgm-6-781] and these patients are empirically initiated on antituberculosis combination therapy and corticosteroids.

Tuberculosis is a major cause of mortality and morbidity.[@b2-ijgm-6-781],[@b3-ijgm-6-781] Tuberculosis manifestations are protean and affect all systems of the body.[@b4-ijgm-6-781] Tuberculosis may cause stridor, either by direct laryngeal involvement[@b5-ijgm-6-781] or indirectly by causing a mediastinal mass.[@b6-ijgm-6-781],[@b7-ijgm-6-781]

The academic literature does not report a case of tuberculosis meningitis causing stridor. However, there have been reports in children whereby raised intracranial pressure, hydrocephalus, and Arnold Chiari malformation have resulted in stridor.[@b8-ijgm-6-781]--[@b10-ijgm-6-781]

Stritzke et al[@b8-ijgm-6-781] reported a case of congenital stridor associated with a low lumbar neural tube defect and Chiari malformation. The authors proposed that the granulomatous meningitis reaction to vernix caseosa may have played a role in the central mechanism for stridor. The most popular hypothesis to explain the mechanism of stridor in Chiari malformation is that brain stem compression and cerebrospinal fluid obstruction secondary to hind brain herniation "\[...\]results in parenchymal dysplasia, scarring, and adhesions that might clinically result in stridor".[@b11-ijgm-6-781] This hypothesis is vague but serves as a starting point for investigation into the actual mechanism by which granulomatous meningitis results in stridor.

Correa-Restrep et al[@b10-ijgm-6-781] reported a case of vernix caseosa meningitis and laryngeal stridor in an infant with myelomeningocele. They suggested that chemical meningitis involving the cranial nerves might account for the laryngeal stridor. They do not describe exactly how cranial nerve involvement results in laryngeal stridor.

In our index patient, complicated tuberculosis meningitis resulted in a cerebrovascular accident with left hemiplegia, probably secondary to arteritis of cerebral vessels.[@b3-ijgm-6-781],[@b12-ijgm-6-781] It is probable that she also developed a hydrocephalus with raised intracranial pressure as a complication of meningitis. Hydrocephalus is a known complication of tuberculosis meningitis,[@b13-ijgm-6-781] with ventricular enlargement present in most patients.[@b3-ijgm-6-781] Hydrocephalus may be secondary to obstruction of the basal cisterns, outflow of the fourth ventricle, or occlusion of the cerebral aqueduct.[@b3-ijgm-6-781]

Anderson et al[@b13-ijgm-6-781] did a retrospective review of 104 patients with tuberculosis meningitis. They reported that complications occurred in 81 (78%) of patients. Hydrocephalus was the second most common complication (42%) and stroke (33%) the third, with hyponatremia being the most common complication (49%). We postulate that the central mechanism for stridor may be multifactorial, including raised intracranial pressure, hydrocephalus, and basilar involvement.

The exact mechanism by which central mechanisms result in stridor remains to be elucidated. It is interesting that, of all the patients who develop hydrocephalus secondary to tuberculosis meningitis, there are no reports of these patients developing stridor. We are unable to explain why our patient developed stridor whereas previous patients with tuberculous meningitis did not develop stridor despite hydrocephalus and raised intracranial pressure. Perhaps the severity of the hydrocephalus and degree of intracranial hypertension were contributory factors to our patient developing stridor. It is also possible that unknown genetic factors may have contributed. In addition, our patient's stridor may have been secondary to direct obstruction of the airway, eg, by mediastinal lymphadenopathy.

Unfortunately limited resources precluded definitive imaging studies and an autopsy. These may have added invaluable information for understanding the cause and mechanism of stridor, be it secondary to a mediastinal mass or a central mechanism.
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###### 

Full blood count

                                                   Laboratory reference range   Day 0   Day 2   Day 7   Day 11   Day 16
  ------------------------------------------------ ---------------------------- ------- ------- ------- -------- --------
  White cell count (×10^9^ cells/L)                4.00--10.00                  7.00    7.60    9.90    5.50     6.70
  Red cell count (×10^12^ cells/L)                 3.80--4.80                   2.84    3.53    2.86    3.25     3.50
  Hemoglobin (g/dL)                                12.0--15.0                   8.7     10.5    8.7     10.0     10.8
  Hematocrit (L/L)                                 0.360--0.460                 0.260   0.330   0.263   0.300    0.323
  Mean cell volume (fL)                            83.0--101.0                  91.8    93.7    92.2    92.2     92.4
  Mean cell hemoglobin (pg)                        27.0--32.0                   30.5    29.8    30.6    30.6     30.8
  Mean cell hemoglobin concentration (g/dL)        31.5--34.5                   33.3    31.8    33.2    33.2     33.3
  Red cell distribution width (%)                  11.6--14.0                   22.6    22.0    22.7    22.9     19.6
  Platelet count (×10^9^ cells/L)                  150--400                     236     264     228     292      176
  Mean platelet volume (fL)                        7.0--11.4                    7.8     8.3     7.4     7.1      7.4
  International normalized ratio (second/second)   0.8--1.2                             1.00    1.23    0.92     1.02
  Prothrombin time (second)                        12.0--13.0                           10.8    13.3    9.9      11.0

###### 

Urea and electrolytes

                                                                           Laboratory reference range   Day 0   Day 2   Day 7   Day 11   Day 16
  ------------------------------------------------------------------------ ---------------------------- ------- ------- ------- -------- --------
  Sodium (mmol/L)                                                          136--145                     125     132     120     133      128
  Potassium (mmol/L)                                                       3.5--5.1                     4.6     3.8     3.9     4.9      3.2
  Chloride (mmol/L)                                                        98--107                      90      92      84      101      98
  Bicarbonate (mmol/L)                                                     23--29                       24      25      23      24       24
  Anion gap (mmol/L)                                                       9--16                        16      19      17      13       9
  Urea (mmol/L)                                                            2.1--7.1                     2.7     4.7     3.4     2.9      1.9
  Creatinine (μmol/L)                                                      49--90                       49      47      37      34       37
  Estimated glomerular filtration rate (MDRD formula) (mL/min/1.73 m^2^)   \>60                         \>60    \>60    \>60    \>60     \>60

**Abbreviation:** MDRD, Modification of Diet in Renal Disease.

###### 

Liver function tests

                                     Laboratory reference range   Day 0   Day 2   Day 7   Day 11   Day 16
  ---------------------------------- ---------------------------- ------- ------- ------- -------- --------
  Total protein (g/L)                60--78                       78      72      64      70       59
  Albumin (g/L)                      35--52                       25      23      20      21       19
  Total bilirubin (μmol/L)           5--21                        7       9       16      6        12
  Alanine transaminase (U/L)         7--35                        43      55      34      126      151
  Alkaline phosphatase (U/L)         42--98                       112     103     109     190      172
  Gamma-glutamyl transferase (U/L)   0--35                        113     111     144     303      234
  C-reactive protein (mg/L)          0--5                                 \>200           104      

###### 

Cerebrospinal fluid analysis

                                                                    Laboratory reference range         Day 0
  ----------------------------------------------------------------- ---------------------------------- -------
  Clarity                                                           Clear                              
  Color before centrifugation                                       Colorless                          
  CSF glucose[\*](#tfn2-ijgm-6-781){ref-type="table-fn"} (mmol/L)   1.2                                
  CSF chloride (mmol/L)                                             118--132                           106
  CSF protein (g/L)                                                 0.15--0.45                         1.37
  Polymorphonuclear cells (cells/μL)                                0                                  0
  Lymphocytes (cells/μL)                                            0                                  32
  Erythrocytes (cells/μL)                                           0                                  0
  Unidentified cells (cells/μL)                                     0                                  0
  India ink stain                                                   Encapsulated yeasts not observed   
  *Cryptococcus* latex antigen test                                 Negative                           

**Notes:**

CSF glucose is normally 60%--80% of plasma glucose in samples taken within 15 minutes of each other. Random blood glucose was 5.8 mmol/L for this patient just before lumbar puncture was done.

**Abbreviation:** CSF, cerebrospinal fluid.

###### 

Molecular investigations for HIV

                               Day 0
  ---------------------------- ---------
  HIV viral load (copies/mL)   678,233

**Abbreviation:** HIV, Human immunodeficiency virus.

###### 

Absolute CD4 count

                                        Day 0              Day 7    
  ------------------------------------- ------------------ -------- ----
  Absolute CD4 count (×10^6^ cells/L)   500.00--2,010.00   155.28   26

###### 

Microbiology

  --------------------------------------------------------------------
  **Stool analysis**
  Appearance: watery
  Leucocytes: not observed
  Erythrocytes: not observed
  Yeasts: Scanty (1+)
  Parasite(s): not observed
  Salmonella species: not isolated
  Shigella species: not observed
  **Tracheal aspirate culture**
  Moderate growth of *Klebsiella pneumoniae*
  **Blood culture**
  No growth after 6 weeks
  **Sputum analysis**
  Auramine stain for acid-fast bacilli negative
  Polymerase chain reaction for *Mycobacteria tuberculosis* negative
  --------------------------------------------------------------------
